Cibus, Inc.
NASDAQ:CBUSBiotechnology
Healthcare
$1.23 +3.10%
+$0.04 today
- Market cap
- $94.01M
- Beta
- 1.65
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.16
52W Low $1.09High $4.19
Volume 0.19M
Average 0.51M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$50.59M
FY 2025 · Annual
Investing Cash Flow
-$578,000.00
FY 2025 · Annual
Financing Cash Flow
$46.65M
FY 2025 · Annual
+14.9% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (29.2M) | (16.89M) | (267.63M) | (282.71M) | (127.09M) |
| Depreciation & Amortization | 2.34M | 1.53M | 4.69M | 6.86M | 5.92M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 2.09M | 4M | 16.09M | 10.75M | 8.19M |
| Change in Working Capital | 7.49M | (2.89M) | 961K | 383K | 2.32M |
| Accounts Receivables | 4.89M | 0 | 1.7M | (512K) | 538K |
| Inventory | 1.38M | 0 | 0 | 0 | 0 |
| Accounts Payables | (360K) | (229K) | 2K | (188K) | 720K |
| Other Working Capital | 1.58M | (2.66M) | (745K) | 1.08M | 1.06M |
| Other Non-Cash Items | (1.53M) | (5.12M) | 215.76M | 206.68M | 60.06M |
| Operating Cash Flow | (18.81M) | (19.36M) | (46.21M) | (58.04M) | (50.59M) |
| Capital Expenditures | (497K) | (1.52M) | (4.32M) | (808K) | (578K) |
| Acquisitions (Net) | 0 | 0 | 59.38M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 11.7M | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 11.2M | (1.52M) | 55.06M | (808K) | (578K) |
| Debt Repayment | (364K) | (376K) | (194K) | (879K) | (1.11M) |
| Common Stock Issued | 4.38M | 11.54M | 18.76M | 43.9M | 47.9M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (274K) | (1.17M) | 1.76M | (2.43M) | (142K) |
| Financing Cash Flow | 3.74M | 9.99M | 20.32M | 40.6M | 46.65M |
| Effect of Forex Changes | 498K | 99K | 3K | (13K) | 11K |
| Net Change in Cash | (3.87M) | (10.9M) | 29.17M | (18.27M) | (4.51M) |
| Free Cash Flow | (19.31M) | (20.88M) | (50.53M) | (58.85M) | (51.17M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$127.1M
+ D&A$5.9M
+ Stock-Based Comp$8.2M
+ Deferred Tax$0
+ Working Capital$2.3M
+ Other Non-Cash$60.1M
= Operating Cash Flow-$50.6M
- Capex-$578.0K
= Free Cash Flow-$51.2M
Analysis
FY2025 free cash flow is -$51.2M. FCF conversion is 40.3% of net income. Operating cash flow was -$50.6M, with capex of -$578.0K. The largest bridge item is Other Non-Cash at $60.1M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 8-K | Current report | Nov 12, 2026 |
Does CBUS generate free cash flow?
Cibus, Inc. (CBUS) generated -$51.17M of free cash flow in fiscal 2025.
How much operating cash flow does CBUS produce?
Operating cash flow was -$50.59M, before capital expenditures of $578,000.00.
Continue the stock analysis
Jump to another research area for this company.